| 1 |
Schöne C, Venner A, Knowles D, Karnani MM, Burdakov D. Dichotomous cellular properties of mouse orexin/hypocretin neurons. J Physiol 2011;589:2767-79. [PMID: 21486780 DOI: 10.1113/jphysiol.2011.208637] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 2 |
Brooks SP, Dunnett SB. Mouse Models of Huntington’s Disease. In: Nguyen HHP, Cenci MA, editors. Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease. Berlin: Springer Berlin Heidelberg; 2015. pp. 101-33. [DOI: 10.1007/7854_2013_256] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 3 |
van Wamelen DJ, Aziz NA. Hypothalamic pathology in Huntington disease. Handb Clin Neurol 2021;182:245-55. [PMID: 34266596 DOI: 10.1016/B978-0-12-819973-2.00017-4] [Reference Citation Analysis]
|
| 4 |
Smarr B, Cutler T, Loh DH, Kudo T, Kuljis D, Kriegsfeld L, Ghiani CA, Colwell CS. Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis. J Neurosci Res 2019;97:1606-23. [PMID: 31359503 DOI: 10.1002/jnr.24505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 5 |
Berhe DF, Gebre AK, Assefa BT. Orexins role in neurodegenerative diseases: From pathogenesis to treatment. Pharmacol Biochem Behav 2020;194:172929. [PMID: 32315694 DOI: 10.1016/j.pbb.2020.172929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 6 |
Morton AJ. Circadian and sleep disorder in Huntington's disease. Exp Neurol 2013;243:34-44. [PMID: 23099415 DOI: 10.1016/j.expneurol.2012.10.014] [Cited by in Crossref: 94] [Cited by in F6Publishing: 89] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 7 |
Brown JA, Woodworth HL, Leinninger GM. To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance. Front Syst Neurosci 2015;9:9. [PMID: 25741247 DOI: 10.3389/fnsys.2015.00009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 8 |
Williams RH, Chee MJ, Kroeger D, Ferrari LL, Maratos-Flier E, Scammell TE, Arrigoni E. Optogenetic-mediated release of histamine reveals distal and autoregulatory mechanisms for controlling arousal. J Neurosci 2014;34:6023-9. [PMID: 24760861 DOI: 10.1523/JNEUROSCI.4838-13.2014] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 9 |
Shan L, Dauvilliers Y, Siegel JM. Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol 2015;11:401-13. [PMID: 26100750 DOI: 10.1038/nrneurol.2015.99] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 10 |
Shan L, Bao AM, Swaab DF. The human histaminergic system in neuropsychiatric disorders. Trends Neurosci 2015;38:167-77. [PMID: 25575625 DOI: 10.1016/j.tins.2014.12.008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 11 |
Fisher SP, Black SW, Schwartz MD, Wilk AJ, Chen TM, Lincoln WU, Liu HW, Kilduff TS, Morairty SR. Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease. Brain 2013;136:2159-72. [PMID: 23801738 DOI: 10.1093/brain/awt132] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 12 |
Abbott SM, Videnovic A. Chronic sleep disturbance and neural injury: links to neurodegenerative disease. Nat Sci Sleep 2016;8:55-61. [PMID: 26869817 DOI: 10.2147/NSS.S78947] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Farajnia S, Meijer JH, Michel S. Age-related changes in large-conductance calcium-activated potassium channels in mammalian circadian clock neurons. Neurobiol Aging 2015;36:2176-83. [PMID: 25735218 DOI: 10.1016/j.neurobiolaging.2014.12.040] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 14 |
Kantor S, Szabo L, Varga J, Cuesta M, Morton AJ. Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutation. Brain 2013;136:2147-58. [PMID: 23801737 DOI: 10.1093/brain/awt128] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 15 |
Al-Kuraishy HM, Abdulhadi MH, Hussien NR, Al-Niemi MS, Rasheed HA, Al-Gareeb AI. Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review. Brain Circ 2020;6:70-80. [PMID: 33033776 DOI: 10.4103/bc.bc_42_19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 16 |
Schöne C, Cao ZF, Apergis-Schoute J, Adamantidis A, Sakurai T, Burdakov D. Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons in situ. J Neurosci 2012;32:12437-43. [PMID: 22956835 DOI: 10.1523/JNEUROSCI.0706-12.2012] [Cited by in Crossref: 95] [Cited by in F6Publishing: 66] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 17 |
Schöne C, Burdakov D. Glutamate and GABA as rapid effectors of hypothalamic "peptidergic" neurons. Front Behav Neurosci 2012;6:81. [PMID: 23189047 DOI: 10.3389/fnbeh.2012.00081] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 18 |
Chen Q, de Lecea L, Hu Z, Gao D. The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Med Res Rev 2015;35:152-97. [PMID: 25044006 DOI: 10.1002/med.21326] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 19 |
Ouk K, Aungier J, Ware M, Morton AJ. Abnormal Photic Entrainment to Phase-Delaying Stimuli in the R6/2 Mouse Model of Huntington's Disease, despite Retinal Responsiveness to Light. eNeuro 2019;6:ENEURO. [PMID: 31744839 DOI: 10.1523/ENEURO.0088-19.2019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 20 |
Concetti C, Burdakov D. Orexin/Hypocretin and MCH Neurons: Cognitive and Motor Roles Beyond Arousal. Front Neurosci 2021;15:639313. [PMID: 33828450 DOI: 10.3389/fnins.2021.639313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Hu B, Yang N, Qiao QC, Hu ZA, Zhang J. Roles of the orexin system in central motor control. Neurosci Biobehav Rev 2015;49:43-54. [PMID: 25511388 DOI: 10.1016/j.neubiorev.2014.12.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 22 |
Jin J, Albertz J, Guo Z, Peng Q, Rudow G, Troncoso JC, Ross CA, Duan W. Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease. J Neurochem 2013;125:410-9. [PMID: 23373812 DOI: 10.1111/jnc.12190] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 23 |
Cheong RY, Gabery S, Petersén Å. The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease. J Huntingtons Dis 2019;8:375-91. [PMID: 31594240 DOI: 10.3233/JHD-190372] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 24 |
Cabanas M, Pistono C, Puygrenier L, Rakesh D, Jeantet Y, Garret M, Cho YH. Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington's Disease. Neurotherapeutics 2019;16:784-96. [PMID: 30915710 DOI: 10.1007/s13311-019-00726-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 25 |
Karnani MM, Apergis-Schoute J, Adamantidis A, Jensen LT, de Lecea L, Fugger L, Burdakov D. Activation of central orexin/hypocretin neurons by dietary amino acids. Neuron 2011;72:616-29. [PMID: 22099463 DOI: 10.1016/j.neuron.2011.08.027] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 26 |
van Wamelen DJ, Aziz NA, Roos RAC, Swaab DF. Hypothalamic Alterations in Huntington's Disease Patients: Comparison with Genetic Rodent Models. J Neuroendocrinol 2014;26:761-75. [DOI: 10.1111/jne.12190] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 27 |
Kosse C, Burdakov D. A unifying computational framework for stability and flexibility of arousal. Front Syst Neurosci 2014;8:192. [PMID: 25368557 DOI: 10.3389/fnsys.2014.00192] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 28 |
Schneider WT, Vas S, Nicol AU, Morton AJ. Abnormally abrupt transitions from sleep-to-wake in Huntington's disease sheep (Ovis aries) are revealed by automated analysis of sleep/wake transition dynamics. PLoS One 2021;16:e0251767. [PMID: 33984047 DOI: 10.1371/journal.pone.0251767] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
González JA, Jensen LT, Fugger L, Burdakov D. Convergent inputs from electrically and topographically distinct orexin cells to locus coeruleus and ventral tegmental area. Eur J Neurosci 2012;35:1426-32. [PMID: 22507526 DOI: 10.1111/j.1460-9568.2012.08057.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
|
